GW&K Investment Management, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
81
-79.1%
0.00%
Q3 2019$1,000
-100.0%
387
-100.0%
0.00%
-100.0%
Q1 2019$25,581,000
+4.0%
1,805,274
-0.7%
0.41%
-15.1%
Q4 2018$24,606,000
-45.9%
1,818,637
-11.3%
0.48%
-33.7%
Q3 2018$45,484,000
+41.6%
2,049,765
+4.7%
0.73%
+39.2%
Q2 2018$32,113,0001,956,9060.53%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders